CILLO, UMBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 38.707
EU - Europa 7.212
AS - Asia 7.163
SA - Sud America 1.512
AF - Africa 204
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 9
Totale 54.838
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 38.525
SG - Singapore 3.308
IT - Italia 2.336
CN - Cina 2.244
BR - Brasile 1.386
DE - Germania 971
FI - Finlandia 932
HK - Hong Kong 702
SE - Svezia 514
PL - Polonia 451
VN - Vietnam 436
GB - Regno Unito 371
FR - Francia 361
RU - Federazione Russa 334
NL - Olanda 319
UA - Ucraina 291
IN - India 149
CA - Canada 92
AT - Austria 72
IE - Irlanda 61
CI - Costa d'Avorio 53
TR - Turchia 47
BD - Bangladesh 42
AR - Argentina 40
MX - Messico 33
ES - Italia 31
ZA - Sudafrica 31
JP - Giappone 28
IQ - Iraq 24
SA - Arabia Saudita 24
MA - Marocco 21
UZ - Uzbekistan 21
CZ - Repubblica Ceca 20
VE - Venezuela 20
BE - Belgio 19
CO - Colombia 18
AU - Australia 15
IL - Israele 15
EC - Ecuador 13
EG - Egitto 11
GR - Grecia 11
BG - Bulgaria 10
IR - Iran 10
PH - Filippine 10
AE - Emirati Arabi Uniti 9
AL - Albania 9
CH - Svizzera 9
CL - Cile 9
KE - Kenya 9
KR - Corea 9
PK - Pakistan 9
RO - Romania 9
TN - Tunisia 9
BZ - Belize 8
KZ - Kazakistan 8
LV - Lettonia 8
MD - Moldavia 8
PA - Panama 8
UY - Uruguay 8
DZ - Algeria 7
LT - Lituania 7
NO - Norvegia 7
NZ - Nuova Zelanda 7
PY - Paraguay 7
TW - Taiwan 7
EU - Europa 6
PE - Perù 6
PT - Portogallo 6
RS - Serbia 6
SC - Seychelles 6
TT - Trinidad e Tobago 6
AM - Armenia 5
BA - Bosnia-Erzegovina 5
BO - Bolivia 5
BY - Bielorussia 5
CR - Costa Rica 5
HU - Ungheria 5
JM - Giamaica 5
JO - Giordania 5
LU - Lussemburgo 5
NP - Nepal 5
TH - Thailandia 5
UG - Uganda 5
AZ - Azerbaigian 4
BB - Barbados 4
GH - Ghana 4
ID - Indonesia 4
KG - Kirghizistan 4
PG - Papua Nuova Guinea 4
TJ - Tagikistan 4
BW - Botswana 3
CM - Camerun 3
ET - Etiopia 3
GA - Gabon 3
GE - Georgia 3
GM - Gambi 3
GN - Guinea 3
HN - Honduras 3
HR - Croazia 3
IS - Islanda 3
Totale 54.747
Salva come PNG Salva come JPEG
Città #
Fairfield 6.203
Woodbridge 4.087
Houston 3.027
Ann Arbor 2.910
Ashburn 2.686
Chandler 2.584
Seattle 2.298
Cambridge 2.073
Wilmington 2.028
Singapore 1.795
Jacksonville 1.316
Boardman 839
Santa Clara 794
Princeton 744
San Diego 707
Hong Kong 639
Des Moines 489
Padova 474
Beijing 458
Bytom 422
Helsinki 417
Dong Ket 414
Medford 401
Nanjing 303
Roxbury 262
Guangzhou 147
Munich 146
Shenyang 136
Nanchang 125
Milan 122
São Paulo 104
New York 99
London 93
Los Angeles 88
Nuremberg 87
Hebei 85
Turku 82
Rome 78
Jinan 69
Shanghai 66
Jiaxing 63
Falls Church 59
Dublin 58
Redwood City 54
Changsha 52
Norwalk 52
Ogden 52
Abidjan 51
Dearborn 50
Chicago 49
Tianjin 49
Bologna 45
Falkenstein 43
Villafranca Padovana 41
Pune 36
Belo Horizonte 35
Rio de Janeiro 35
Verona 33
Curitiba 32
Vienna 30
Dallas 29
Treviso 29
Kunming 28
Turin 28
Detroit 27
Frankfurt am Main 27
Toronto 27
Washington 27
Indiana 26
Las Vegas 26
Zhengzhou 26
Hangzhou 25
Hefei 25
Kharkiv 24
Naples 24
San Francisco 24
San Jose 24
Venice 24
Brasília 23
Kilburn 23
Ningbo 23
Taizhou 23
Nürnberg 22
Tashkent 21
Buffalo 20
Florence 20
Istanbul 20
Lauterbourg 20
Borås 19
Düsseldorf 19
Lappeenranta 19
Fuzhou 18
Palermo 18
Dhaka 17
Lanzhou 17
Guarulhos 16
Tokyo 16
Warsaw 16
Amsterdam 15
Johannesburg 15
Totale 41.706
Salva come PNG Salva come JPEG
Nome #
TRAPIANTO DI FEGATO CON EMITRASPOSIZIONE PORTO-CAVALE IN PAZIENTE CON BASM SYNDROME 769
Pancreatic surgery outcomes: multicentre prospective snapshot study in 67 countries 231
Importance of primary indication and liver function between stages: Results of a multicenter Italian audit of ALPPS 2012-2014 190
Cavoportal hemitransposition associated to portoportal anastomosis for liver transplant in portomesenteric thrombosis. 184
The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: Results of a randomized, controlled clinical trial 182
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study. 177
A novel approach to severe acute pancreatitis in sequential liver-kidney transplantation:the first report on the application of VAC therapy 174
Circulating free DNA in the progression of liver damage to hepatocellular carcinoma 174
Treatment of hepatocellular carcinoma in the Precision Medicine era: from treatment stage migration to therapeutic hierarchy 173
Alcohol abuse and de novo tumors in liver transplantation 170
Use of N-acetylcysteine during liver procurement: A prospective randomized controlled study. 167
When to perform hepatic resection for intermediate-stage hepatocellular carcinoma 167
A National Mandatory-Split Liver Policy: A Report from the Italian Experience 165
Model for end-stage liver disease-sodium and survival benefit in liver transplantation. 164
A New Liver Autotransplantation Technique Using Subnormothermic Machine Perfusion for Organ Preservation in a Porcine Model 161
Use of grafts from anti-HBc-positive donors in liver transplantation: a 5-year, single-center experience. 159
Prognostic impact of model for end-stage liver disease score in patients undergoing liver transplantation with suboptimal livers. 158
Courage and representations of death in patients who are waiting for a liver transplantation 158
Renal failure and bacterial infections in patients with cirrhosis: Epidemiology and clinical features 157
Validation of the BCLC prognostic system in surgical hepatocellular cancer patients. 157
Cost-effectiveness of Pre-Transplant Sofosbuvir for Preventing Recurrent HCV Infection after Liver Transplantation. 157
Prognostic Evaluation of the Donor Risk Index Among a Prospective Cohort of Italian Patients Undergoing Liver Transplantation 157
Sequential versus "ab initio' combined diuretic treatment of moderate ascites in cirrhotic patients: Final results of a randomized controlled multicenter clinical study 155
Fulminant hepatic failure: the issue of patient selection for hazardous liver assistance 154
Prospective validation of the Barcelona Clinic Liver Cancer staging system 154
Partial hepatectomy as first-line treatment for patients with hepatocellular carcinoma 153
Isoniazid-related fulminant hepatic failure in a child: assessment of the native liver's early regeneration after auxiliary partial orthotopic liver transplantation. 150
Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma 150
A PRIORITIZATION MODEL FOR LIVER TRANSPLANTATION BASED ON A DUAL WAITING LIST: A PROSPECTIVE CONTROLLED STUDY 149
Prognostic role of BAP-1 and PBRM-1 expression in intrahepatic cholangiocarcinoma 149
Administration of hepatic stimulatory substance alone or with other liver growth factors does not ameliorate acetaminophen-induced liver failure. 148
A new experimental model of isolated perfused pig liver to support acute hepaticfailure. 148
Torque Teno Virus: any pathological role in liver transplanted patients? 148
Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial 146
Multicentre evaluation of case volume in minimally invasive hepatectomy 146
Colonization and infection due to carbapenemase-producing Enterobacteriaceae in liver and lung transplant recipients and donor-derived transmission: a prospective cohort study conducted in Italy 146
Cross-talk between PDGF and S1P signalling elucidates the inhibitory effect and potential antifibrotic action of the immunomodulator FTY720 in activated HSC-cultures. 145
Differential timing of oxidative DNA damage and telomere shortening in hepatitis C and B virus-related liver carcinogenesis 145
Representing Subnormothermic Machine Perfusion in Fatty Livers: The Complete Picture? 145
Monoclonal gammopathy after liver transplantation: a risk factor for long-term medical complications other than malignancies. 145
The concept of therapeutic hierarchy for patients with hepatocellular carcinoma: A multicenter cohort study 144
Including Relative Adrenal Insufficiency in Definition and Classification of Acute-on-Chronic Liver Failure 144
A multicenter pilot prospective study comparing Celsior and University of Wisconsin preserving solutions for use in liver transplantation 143
Continuous recurrence of type 1 hepatorenal syndrome and long-term treatment with terlipressin and albumin: A new exception to MELD score in the allocation system to liver transplantation? 143
Adjuvant chemotherapy for transplanted hepatocellular carcinoma patients: impact on survival or HCV recurrence timing 142
Liver radiofrequency ablation as emergency treatment for a ruptured hepatocellular carcinoma: a case report 141
Nonadherent Behaviors After Solid Organ Transplantation 140
The survival benefit of liver transplantation in hepatocellular carcinoma patients 140
Reply: The easiest way to improve the outcome of suboptimal liver grafts 140
Hepatitis C Virus Adversely Affects Quality of Life 140
Human Liver Autofluorescence: An Intrinsic Tissue Parameter Discriminating Normal and Diseased Conditions 139
Double autologous bone marrow transplantation and orthotopic liver transplantation in a patient with primary light chain (AL) amyloidosis. 139
Psychosocial Support in Liver Transplantation: A Dyadic Study With Patients and Their Family Caregivers 139
A Multistep, Consensus-Based Approach to Organ Allocation in Liver Transplantation: Toward a "blended Principle Model" 138
Drop-out rate from the liver transplant waiting list due to HCC progression in HCV-infected patients treated with direct acting antivirals. 138
The two faces of hepatocellular carcinoma prognostic evaluation: 'observational' or 'pragmatic' approach? 138
12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus. 137
Growth hormone/insulin-like growth factor 1 axis recovery after liver transplantation: A preliminary prospective study 137
Covert hepatic encephalopathy: agreement and predictive validity of different indices 137
146 EARLY INTRODUCTION OF EVEROLIMUS IN DE NOVO LIVER TRANSPLANTATION: A MULTICENTER RANDOMIZED CLINICAL TRIAL (EPOCAL) 137
Successful transplantation of an injured liver 136
Intention-to-treat analysis of liver transplantation in selected, aggressively treated HCC patients exceeding the milan criteria 136
The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available? 136
Correction to: Diffusion, outcomes and implementation of minimally invasive liver surgery: a snapshot from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry (Updates in Surgery, (2017), 69, 3, (271-283), 10.1007/s13304-017-0489-x) 136
A comparative prospective study of two available solutions for kidney and liver preservation 135
Liver Resection Associated With Mini Porto-Caval Shunt as Salvage Treatment in Patients With Progression of Hepatocellular Carcinoma Before Liver Transplantation: A Case Report 135
A randomized study comparing ligation with propranolol for primary prophylaxis of variceal bleeding in candidates for liver transplantation. 135
Surgery for cholangiocarcinoma 135
Syngeneic living-donor liver transplantation for hemangioendothelioma: a clinical model for studying liver regeneration 134
Alphafetoprotein and Transplant Survival Benefit For Patients With Hepatocellular Carcinoma: A Multicentre Cohort Study 134
Laparoscopic microwave thermal ablation for late recurrence of local hepatocellular carcinoma after liver transplant: case report. 134
Hepatic Resection for Disappearing Liver Metastasis: a Cost-Utility Analysis 134
Antibiotic prophylaxis for preventing postorthotopic liver transplant tuberculosis: is there a safe alternative to isoniazid? 134
Extraordinary disease-free survival in a rare malignant extrarenal rhabdoid tumor: A case report and review of the literature 134
A novel approach to severe acute pancreatitis in sequential liver-kidney transplantation: the first report on the application of VAC therapy 133
Microwave Thermal Ablation for Hepatocarcinoma: Six Liver Transplantation Cases 133
Molecular refinement of clinical staging in hepatocellular carcinoma patients evaluated for potentially curative therapies. 133
Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC 133
Platelets and Hepatocellular Cancer: Bridging the Bench to the Clinics 133
Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study. 132
LAPAROSCOPIC ABLATION AND SALVAGE TRANSPLANTATION FOR PATIENTS WITH HEPATOCELLULAR CARCINOMA 132
Percutaneous radiofrequency thermal ablation for hepatocellular carcinoma. 132
Donor-Model for End-Stage Liver Disease and Donor-Recipient Matching in Liver Transplantation 131
Laparoscopic liver resection of hepatocellular carcinoma located in unfavorable segments: a propensity score-matched analysis from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry 131
Resminostat plus sorafenib as second-line therapy of advanced hepatocellular carcinoma - The SHELTER study 131
SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity 131
Predictors of unresectability in hepatoblastoma: A 20-year single centre report 130
Response to therapy as a criterion for awarding priority to patients with hepatocellular carcinoma awaiting liver transplantation. 130
Videolaparoscopic microwave ablation in patients with HCC at a European high-volume center: Results of 815 procedures 130
Laparoscopic Ablation of Hepatocellular Carcinoma in Cirrhotic Patients Unsuitable for Liver Resection or Percutaneous Treatment: A Cohort Study 130
A novel approach to severe acute pancreatitis in sequential liver-kidney transplantation: the first report on the application of VAC therapy 129
Meld-na and Survival Benefit In Liver Transplantation 129
Neoadjuvant sirolimus for a large hepatic perivascular epithelioid cell tumor (PEComa) 129
A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list. 129
Assessment and prevention of cytomegalovirus infection in allogeneic hematopoietic stem cell transplant and in solid organ transplant: A multidisciplinary consensus conference by the Italian GITMO, SITO, and AMCLI societies 129
Role of blood AFP mRNA and tumor grade in the preoperative prognostic evaluation of patients with hepatocellular carcinoma 128
Prognostic impact of FGFR2/3 alterations in patients with biliary tract cancers receiving systemic chemotherapy: the BITCOIN study 128
Erratum to: A Regenerative Approach with Dermal Micrografts in the Treatment of Chronic Ulcers 127
"DAA in patients with Hepatocellular carcinoma before Liver Transplantation: are we sure is still an open issue?" 127
The Psychosocial Assessment of Transplant Candidates: Inter-Rater Reliability and Predictive Value of the Italian Stanford Integrated Psychosocial Assessment for Transplantation 127
Totale 15.098
Salva come PNG Salva come JPEG
Categoria #
all - tutte 211.488
article - articoli 186.305
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 690
Totale 398.483
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020394 0 0 0 0 0 0 0 0 0 0 0 394
2020/20217.095 394 576 411 566 272 472 397 632 915 800 793 867
2021/20228.287 238 898 985 522 319 537 1.229 661 353 180 934 1.431
2022/20235.746 1.133 523 108 682 872 826 121 402 717 53 230 79
2023/20243.362 201 492 349 262 222 276 254 193 142 222 354 395
2024/202511.974 46 925 642 508 1.733 444 686 1.066 1.188 569 2.314 1.853
Totale 55.470